Skip to main content

omadacycline

Generic: OMADACYCLINE TOSYLATE·Brand: NUZYRA, Nuzyra

omadacycline: 2 clinical trials tracked.

omadacycline evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about omadacycline, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trial Registry Records (2)

A Phase 1, Open-Label, Multi-Center Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Intravenous and Oral Doses of Omadacycline in Pediatric Subjects With Suspected or Confirmed Bacterial Infections

NCT05217537Registry updated 2026-03-09·Phase 1·PRTK
Completed

Primary endpoint: Area Under the Plasma Concentration Versus Time Curve (AUC) From Time 0 to 48hours (AUC0-48) of Omadacycline After IV Infusion

Interventionalopen23 enrolledStarted 2022-04Completion 2025-029 sites · United StatesParatek Pharmaceuticals Inc

A Ph. 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, & Tolerability of Oral Omadacycline in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex

NCT04922554Registry updated 2025-07-30·Phase 2·PRTK
Completed

Primary endpoint: Percentage of Participants With Clinical Response on NTM Symptom Assessment Scale at Day 84

InterventionalRandomizedquadruple66 enrolledStarted 2021-10Completion 2024-0717 sites · United StatesParatek Pharmaceuticals Inc